Therapeutic options for HIV-associated lymphomas

Author： Spina Michele   Gloghini Annunziata   Tirelli Umberto   Carbone Antonino  

Publisher： Informa Healthcare

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.11, Iss.15, 2010-10, pp. : 2471-2481

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

CXCL8 as a Potential Therapeutic Target for HIV-Associated Neurocognitive Disorders

By  

Current Drug Targets, Vol. 17, Iss. 1, 2016-01 ,pp. : 111-121

Bentham Science Publishers

Access to resources Recommend Favorite

Maximising therapeutic options for HIV infection

By  

Inpharma, Vol. 1, Iss. 1351, 2002-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

Somatropin promising in HIV-associated lipodystrophy

By  

Inpharma, Vol. 1, Iss. 1311, 2001-01 ,pp. : 16-16

Adis International

Access to resources Recommend Favorite

Systemic immune activation in HIV and potential therapeutic options

By Sinha Bhaswati   Rubens Muni  

Immunopharmacology and Immunotoxicology, Vol. 36, Iss. 2, 2014-04 ,pp. : 89-95

Informa Healthcare

Access to resources Recommend Favorite

MYC-associated and double-hit lymphomas: A review of pathobiology, prognosis, and therapeutic approaches

By  

Cancer, Vol. 120, Iss. 24, 2014-12 ,pp. : 3884-3895

Blackwell Publishing

Access to resources Recommend Favorite